Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
Go back to Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results| (NASDAQ: FULC) | Delayed: 3.70 +0.20 (5.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.50 | 52 Week High | $ | |||
| Open | $3.56 | 52 Week Low | $ | |||
| Day High | $3.71 | P/E | N/A | |||
| Day Low | $3.46 | EPS | $ | |||
| Volume | 6,101,106 | |||||

